| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,547,000 | 3,202,000 | 3,458,000 | 3,236,000 | | Cost of Revenue | 2,077,000 | 1,933,000 | 2,138,000 | (1,651,000) | | | Gross Profit | 1,470,000 | 1,269,000 | 1,320,000 | 4,887,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 193,000 | 192,000 | 197,000 | 4,108,000 | | Non Recurring | (2,000) | (2,000) | (9,000) | (2,000) | | Others | 421,000 | 397,000 | 382,000 | 360,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 858,000 | 682,000 | 750,000 | 421,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,000 | 7,000 | 14,000 | 44,000 | | Earnings Before Interest And Taxes | 875,000 | 689,000 | 764,000 | 464,000 | | Interest Expense | 225,000 | 220,000 | 222,000 | 288,000 | | Income Before Tax | 650,000 | 469,000 | 542,000 | 176,000 | | Income Tax Expense | 208,000 | 148,000 | 179,000 | 34,000 | | Minority Interest | (5,000) |
-
|
-
| (2,000) | | | | Net Income From Continuing Ops | 441,000 | 322,000 | 363,000 | 141,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 11,000 | | Extraordinary Items |
-
| (5,000) |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 441,000 | 317,000 | 363,000 | 152,000 | | Preferred Stock And Other Adjustments | 3,000 |
-
| (3,000) |
-
| | | Net Income Applicable To Common Shares | $444,000 | $317,000 | $360,000 | $152,000 |
|
1.52% Nasdaq 
Income Statement
